FOLH1 and neoplasm: They successfully radiolabelled their new compound with titanium-45 and demonstrated that in tumour-bearing mice bearing both PSMA-positive and PSMA-negative tumours, [45Ti]Ti-ENT-DUPA selectively accumulated in the PSMA-positive tumours and was mainly excreted via the kidneys124.